Showing results (321-330 of 456) with videos related to
Sort By:
Pageof 46
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 19, 2026
No impact of low-dose nivolumab addition to JNJ-73763989 on HBsAg declines in chronic hepatitis B: the OCTOPUS-1 studyTarik Asselah, Scott K Fung, Sila Akhan, et al.Journal of Gastroenterology and Hepatology|March 23, 2016
A phase 3, open-label study of daclatasvir plus asunaprevir in Asian patients with chronic hepatitis C virus genotype 1b infection who are ineligible for or intolerant to interferon alfa therapies with or without ribavirinLai Wei, Mingxiang Zhang, Min Xu, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 3, 2016
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infectionJia-Horng Kao, Rong-Nan Chien, Ting-Tsung Chang, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 12, 2018
Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutionsMing-Lung Yu, Chao-Hung Hung, Yi-Hsiang Huang, et al.Journal of Hepatology|November 5, 2019
Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1-6 and compensated cirrhosis: The EXPEDITION-8 trialRobert S Brown, Maria Buti, Lino Rodrigues, et al.Journal of the Chinese Medical Association : JCMA|January 12, 2021
Genotype distribution, clinical characteristics, and racial differences observed in chronic hepatitis C patients in Pingtung, TaiwanTyng-Yuan Jang, Po-Cheng Liang, Ta-Wei Liu, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 21, 2026
Safety, Tolerability, and Pharmacodynamics of GS-4224 in Healthy Participants and Participants With Chronic Hepatitis BEdward J Gane, Chi-Yi Chen, Cheng-Hao Tseng, et al.The Kaohsiung Journal of Medical Sciences|November 17, 2021
Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in nonalcoholic steatohepatitis patientsTyng-Yuan Jang, Chung-Feng Huang, Ming-Lun Yeh, et al.Medicine|April 4, 2015
Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in TaiwanMing-Lung Yu, Ming-Lun Yeh, Pei-Chien Tsai, et al.The American Journal of Gastroenterology|March 27, 2024
Long-term Risks of Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease SubtypesYi-Ting Chen, Tzu-I Chen, Tsai-Hsuan Yang, et al.Pageof 46